Jafron Biomedical Co.,Ltd. (JAFRON BIOMEDICAL CO LTD) aktie
300529.SZ
JAFRON BIOMEDICAL CO LTD
Market Cap
$13,384,624,128
Om Jafron Biomedical Co.,Ltd. (JAFRON BIOMEDICAL CO LTD) aktie
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Företagsinformation
519085 Zhuhai, China
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.